Advanced CKD Doesn’t Derail Empagliflozin in EMPEROR-Preserved
Chronic kidney disease (CKD) had no impact on the efficacy or safety of the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin […]
The featured report from the 6,000-patient EMPEROR-Preserved trial at the virtual annual congress of the European Society of Cardiology drew […] Heart failure hospitalizations and costs related to methamphetamine use jumped sharply over a decade in California, according to new research […] Blocking the fat-busting enzyme lipoxygenase with a synthetic inhibitor throws the immune system's innate inflammatory response out of whack, compromising […] The US Food and Drug Administration has declared Medtronic’s recall of seven models of defibrillating cardiac rhythm devices, due to […] The hospital and post-discharge course of patients diagnosed with type-2 myocardial infarction (MI), triggered when myocardial oxygen demand outstrips supply, […] As part of the University Health Network, renowned cardiologist Dr. Heather Ross has launched a new clinical study, in collaboration […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. COSOPT® PRESERVATIVE FREE Preservative Free Dorzolamide hydrochloride/Timolol […]heart failure
Empagliflozin Win in EMPEROR-Preserved HF, but Renal Outcomes Puzzle
Study highlights burden of methamphetamine-associated heart failure hospitalizations in California
Blocking fat-busting enzyme with a drug compromises cardiac repair during acute heart failure
Medtronic Recall of Almost 240,000 ICDs Is Class I, FDA Says
New Light Cast on Type-2 MI Aims to Sharpen Diagnosis, Therapy
New study to explore how Apple Watch can provide early warning for worsening heart failure
Cosopt Preservative Free Eye Drops
